To the casual observer, it took just 10 months to develop a vaccine against the virus responsible for the COVID-19 pandemic. That extraordinary success was made possible by the use of messenger RNA (mRNA), the molecule that instructs cells to make a virus surface protein that stimulates the production of antiviral antibodies.
What most people don't know is that this apparently breakthrough technology had been in development for three frustrating decades. And that it was preceded by 30 earlier years of fundamental research. This book tells the story of how mRNA's medical potential was finally realized, setting the stage for a coming revolution in which our own bodies will generate therapeutic molecules we need. mRNA was long overlooked by mainstream molecular biologists. The pathway to recognition of its therapeutic possibilities was littered with broken careers, lawsuits, and opportunities missed by pharmaceutical companies. For the scientists who persisted through years of academic and commercial disappointment, the COVID-19 vaccine was an enormous vindication and an important step toward a new generation of therapies. Fabrice Delaye, a science and technology reporter for Heidi.news in Switzerland, interviewed more than 40 scientists and entrepreneurs worldwide to create this definitive account of the rise of a technology that promises to revolutionize medicine.Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Fabrice Delaye is a science and technology journalist based in Switzerland. He was U.S. correspondent at the daily Swiss newspaper L'Agefi, science and technology editor at magazine Bilan, and is now a reporter-at-large for Heidi.news in Geneva. He is a graduate of the Institut d'Études Politiques de Paris and has a master's degree from the Swiss Institute of Technology in Lausanne, EPFL.
When COVID-19 imposed its relentless grip on the global population and messenger RNA-based vaccines came to the rescue in seemingly record time, Delaye realized that their development could not have been as simple and quick as people wanted to believe. But it was not until he went in pursuit of the origins of mRNA technologies that he uncovered a dramatic story that had never been told. Maximizing his decades of contacts and his unique grasp of the science and the stakes involved, Delaye set out to document the long, harrowing, unlikely but ultimately triumphant road to discovery of RNA-based technology with the potential to transform the world far beyond the pandemic.„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Zoom Books Company, Lynden, WA, USA
Zustand: very_good. Book is in very good condition and may include minimal underlining highlighting. The book can also include "From the library of" labels. May not contain miscellaneous items toys, dvds, etc. . We offer 100% money back guarantee and 24 7 customer service. Bestandsnummer des Verkäufers ZBV.1621824942.VG
Anzahl: 1 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 45754065
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New. Bestandsnummer des Verkäufers 45754065-n
Anzahl: Mehr als 20 verfügbar
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
Hardback. Zustand: New. Bestandsnummer des Verkäufers LU-9781621824947
Anzahl: 12 verfügbar
Anbieter: PBShop.store US, Wood Dale, IL, USA
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers CW-9781621824947
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers CW-9781621824947
Anzahl: 15 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Hardcover. Zustand: Brand New. 1st edition. 117 pages. 9.00x6.25x0.75 inches. In Stock. Bestandsnummer des Verkäufers __1621824942
Anzahl: 2 verfügbar
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Hardcover. Zustand: new. Hardcover. To the casual observer, it took just 10 months to develop a vaccine against the virus responsible for the COVID-19 pandemic. That extraordinary success was made possible by the use of messenger RNA (mRNA), the molecule that instructs cells to make a virus surface protein that stimulates the production of antiviral antibodies. What most people don't know is that this apparently breakthrough technology had been in development for three frustrating decades. And that it was preceded by 30 earlier years of fundamental research. This book tells the story of how mRNA's medical potential was finally realized, setting the stage for a coming revolution in which our own bodies will generate therapeutic molecules we need. mRNA was long overlooked by mainstream molecular biologists. The pathway to recognition of its therapeutic possibilities was littered with broken careers, lawsuits, and opportunities missed by pharmaceutical companies. For the scientists who persisted through years of academic and commercial disappointment, the COVID-19 vaccine was an enormous vindication and an important step toward a new generation of therapies. Fabrice Delaye, a science and technology reporter for Heidi.news in Switzerland, interviewed more than 40 scientists and entrepreneurs worldwide to create this definitive account of the rise of a technology that promises to revolutionize medicine. Originally published in French: La Raevolution de l'ARN messager: vaccins et nouvelles thaerapies. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9781621824947
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Bestandsnummer des Verkäufers ria9781621824947_new
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 45754065-n
Anzahl: Mehr als 20 verfügbar